MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study

    T. Thomsen, S. Skovbølling, M. Brønden, M. Møller, J. Frederiksen, B. Biering-Sørensen (Roskilde, Denmark)

    Objective: This study aims to test a 8-week self-management program, developed collaboratively with People with PD (PwP), caregivers, healthcare professionals and other stakeholders using a…
  • 2024 International Congress

    Increasing access to Deep Brain Stimulation for an underserved patient population: A retrospective cohort from an urban hospital in a diverse county in the USA.

    Y. Xu, J. Acquaviva, A. Castillo, B. Puccio, E. Feinstein (Newark, USA)

    Objective: To understand whether the presence of a Bilingual Movement Disorder specialist increases access to Deep Brain Stimulation (DBS) for an underserved patient population. Background:…
  • 2024 International Congress

    Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of the first interventional study in  Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…
  • 2024 International Congress

    Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

    Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)

    Objective: To establish α-synuclein seeding activity in saliva as a noninvasive diagnostic biomarker for Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative…
  • 2024 International Congress

    Influence of immigration on Parkinson’s disease: analysis of clinical presentation.

    A. Peral Quirós, N. Caballol Pons, A. Planas Ballvé, M. Balagué Marmaña, MI. Gómez Ruiz, A. ávila Rivera (Barcelona, Spain)

    Objective: To analyze the epidemiological and clinical presentation in our immigrants patients with Parkinson’s disease (PD) from our reference population in Barcelona, Spain. Background: In…
  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

    KC. Dey, D. Mair, A. Zirra, E. Camboe, T. Zannat, S. Haque, RS. Weil, DA. Gallagher, C. Budu, T. Haque, S. Ali, N. Mukadam, A. Habib, AJ. Noyce, CR. Marshall, S. Waters (London, United Kingdom)

    Objective: To establish whether a visuoperceptual tool (the Cats-and-Dogs test) can predict cognitive impairment (CI) in people with Parkinson’s disease (PwP) in a diverse population.…
  • 2024 International Congress

    How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored differences in communication abilities in people with Parkinson’s disease (PwP) with mild cognitive impairment (MCI) (PwP-MCI) and those with normal cognition (PwP-CN).…
  • 2024 International Congress

    Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease

    P. Marcott, A. Nelson (San Francisco, USA)

    Objective: To examine sleep architecture in a commonly studied mouse model of Parkinson’s disease (PD) to better understand underlying circuit mechanisms of sleep disturbances in…
  • 2024 International Congress

    A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

    B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

    Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley